Monitoring local delivery of vancomycin from gelatin nanospheres in zebrafish larvae by Zhang, Xiaolin et al.
PDF hosted at the Radboud Repository of the Radboud University
Nijmegen
 
 
 
 
The following full text is a publisher's version.
 
 
For additional information about this publication click this link.
http://hdl.handle.net/2066/195862
 
 
 
Please be advised that this information was generated on 2019-06-02 and may be subject to
change.
© 2018 Zhang et al. This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php 
and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you 
hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission 
for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
International Journal of Nanomedicine 2018:13 5377–5394
International Journal of Nanomedicine Dovepress
submit your manuscript | www.dovepress.com
Dovepress 
5377
O r I g I N a l  r e s e a r c h
open access to scientific and medical research
Open access Full Text article
http://dx.doi.org/10.2147/IJN.S168959
Monitoring local delivery of vancomycin from 
gelatin nanospheres in zebrafish larvae
Xiaolin Zhang1,2,*
Jiankang song3,*
alexey Klymov3,*
Yang Zhang3
leonie de Boer1
John a Jansen3
Jeroen JJP van den Beucken3
Fang Yang3
sebastian aJ Zaat1,*
sander cg 
leeuwenburgh3,*
1Department of Medical Microbiology, 
amsterdam Infection and Immunity 
Institute, academic Medical center, 
University of amsterdam, amsterdam, 
the Netherlands; 2Department of 
Biomaterials science and Technology, 
MIra Institute for Biomedical 
Technology and Technical Medicine, 
University of Twente, enschede, 
the Netherlands; 3Department of 
Biomaterials, radboud University 
Medical centre, Nijmegen, 
the Netherlands
*These authors contributed equally 
to this work
Background: Infections such as biomaterial-associated infection and osteomyelitis are often 
associated with intracellular survival of bacteria (eg, Staphylococcus aureus). Treatment of these 
infections remains a major challenge due to the low intracellular efficacy of many antibiotics. 
Therefore, local delivery systems are urgently required to improve the therapeutic efficacy of 
antibiotics by enabling their intracellular delivery.
Purpose: To assess the potential of gelatin nanospheres as carriers for local delivery of van-
comycin into macrophages of zebrafish larvae in vivo and into THP-1-derived macrophages 
in vitro using fluorescence microscopy. 
Materials and methods: Fluorescently labeled gelatin nanospheres were prepared and 
injected into transgenic zebrafish larvae with fluorescent macrophages. Both the biodistribution 
of gelatin nanospheres in zebrafish larvae and the co-localization of vancomycin-loaded gelatin 
nanospheres with zebrafish macrophages in vivo and uptake by THP-1-derived macrophages in 
vitro were studied. In addition, the effect of treatment with vancomycin-loaded gelatin nano-
spheres on survival of S. aureus-infected zebrafish larvae was investigated.
Results: Internalization of vancomycin-loaded gelatin nanospheres by macrophages was 
observed qualitatively both in vivo and in vitro. Systemically delivered vancomycin, on the 
other hand, was hardly internalized by macrophages without the use of gelatin nanospheres. 
Treatment with a single dose of vancomycin-loaded gelatin nanospheres delayed the mortality of 
S. aureus-infected zebrafish larvae, indicating the improved therapeutic efficacy of vancomycin 
against (intracellular) S. aureus infection in vivo.
Conclusion: The present study demonstrates that gelatin nanospheres can be used to facilitate 
local and intracellular delivery of vancomycin. 
Keywords: in vivo real-time monitoring, fluorescence microscopy, biodistribution, cell-material 
interaction, Staphylococcus aureus, intracellular infection
Introduction
Bacteria such as Staphylococcus aureus (S. aureus) are responsible for various 
infectious diseases such as pneumonia, bacteremia, diabetic foot infection, osteomy-
elitis, endocarditis, and biomaterial-associated infection.1–4 Such infections are often 
chronic and difficult to treat since S. aureus is a facultative intracellular pathogen, and 
even host phagocytes often fail to kill these intracellular bacteria.5–8 Although some 
antibiotics (eg, quinolones) are effective to treat intracellular infection, unfortunately, 
many antibiotics and other antimicrobial agents (eg, macrolides, aminoglycosides, 
oxazolidinone, β-lactams, glycopeptides, ansamycin, and antimicrobial peptides) have 
limited antibacterial activity against intracellular bacteria due to low cell penetration 
rates, low intracellular retention, or development of resistance.9,10 Therefore, several 
types of nanocarriers (eg, liposomes, nanoparticles, dendrimers, and polymersomes) 
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have been designed to improve local delivery of antibiotics 
and enhance their efficacy against intracellular bacterial 
infections.11,12 Different raw materials such as natural poly-
mers (eg, collagen13 and alginate14) and synthetic polymers 
(eg, poly (lactide-co-glycolide) [PLGA]15 and poly (amino 
acids))16 have been used to develop these delivery systems, 
but none of them is optimal yet. For instance, collagen 
and alginate are relatively expensive and often contain 
impurities,11 while several synthetic polymers such as PLGA 
are degraded to acidic products reducing the pH in the local/
systemic microenvironment which may affect cell func-
tion negatively.17 Therefore, only few formulations based 
on polymeric micro/nanoparticles have been approved for 
market introduction.12 More importantly, no delivery systems 
are available yet, which support complete eradication of 
intracellular bacteria.11 
Gelatin nanospheres are promising carriers for local 
delivery of antibiotics based on their inherent advantages. 
First of all, gelatin has been widely used for biomedical 
research owing to its biocompatibility, biodegradability, 
and cost-effectiveness.18–21 Second, the charged nature of 
gelatin nanospheres facilitates controlled delivery and release 
of oppositely charged macromolecules such as growth 
factors22–24 and nucleic acids25,26 as well as small biomolecules 
such as vancomycin and colistin.27–29 Third, the cross-linking 
density of gelatin nanospheres can be simply adjusted to 
tune the degradation rate of gelatin nanospheres.22,24,27,30 
Finally, the potential of gelatin nanospheres as carriers for 
local delivery of biomolecules was confirmed previously 
in vitro.26,31 This potential was, however, not yet confirmed 
in vivo due to lack of suitable animal models. In addition, the 
spatial distribution of gelatin nanospheres in vivo is largely 
unknown, even though this biodistribution strongly deter-
mines the final applicability of gelatin nanospheres as carriers 
for site-specific delivery of drugs. Hence, in vivo assessment 
of the biodistribution of gelatin nanospheres as well as their 
potential for local delivery of antibiotics is highly desired to 
further the development of gelatin nanosphere-based delivery 
systems for infection treatment.
Zebrafish larvae have been used as in vivo models to 
study infection pathogenesis32,33 and assess the therapeutic 
efficacy of drug-delivery systems.34,35 Advantages of the use 
of zebrafish larvae include the following: strong resemblance 
of their immune system to the human immune system, their 
high fecundity as well as their external fertilization, rapid 
development, and easy maintenance.36–38 These features ren-
der zebrafish larvae a cost- and space-effective animal model 
with the potential for medium- to high-throughput analyses 
for in vivo research.32,39 Moreover, the optical transparency of 
zebrafish larvae enables real-time visualization and intravital 
analysis of cellular responses to pathogens or materials.34,37,40 
To this end, a variety of transgenic zebrafish lines expressing 
different fluorescent proteins in different types of cells (eg, 
macrophages and neutrophils) has been developed.37
The aim of the present study was to evaluate the cellular 
response to gelatin nanospheres in vivo in zebrafish larvae 
and assess the potential of gelatin nanospheres as carriers 
to allow for internalization of vancomycin by macrophages, 
as studied in live larvae using fluorescence microscopy. 
To this end, we labeled gelatin nanospheres and vancomycin 
with fluorescence to study 1) the biodistribution of gelatin 
nanospheres and 2) the internalization of vancomycin by 
fluorescent macrophages of zebrafish larvae (in vivo) as 
well as THP-1-derived macrophages (in vitro). Vancomycin 
was selected as model antibiotic since it has limited anti-
bacterial activity inside cells.7,9,41 In addition, we compared 
the effect of systemic versus local delivery of vancomycin 
(from gelatin nanospheres) on survival of S. aureus-infected 
zebrafish larvae. We observed in a qualitative manner that 
vancomycin was internalized by macrophages upon delivery 
from gelatin nanospheres both in vitro and in vivo. Moreover, 
a single dose of local delivery of vancomycin from gelatin 
nanospheres improved the survival of S. aureus-infected 
zebrafish larvae, which warrants further in vivo pharma-
cokinetic studies in a quantitative manner in an alternative 
in vivo model.
Materials and methods
Materials
Gelatin B was obtained from Sigma-Aldrich (Zwijndrecht, 
the Netherlands) with Bloom number of 225 and an iso-
electric point of ~5. A 25 wt% glutaraldehyde solution (in 
water) was obtained from Acros Organics (Geel, Belgium). 
DyLight™ 650 NHS Esters and BODIPY-FL®-conjugated 
vancomycin (designated as fluorescent-labeled vancomycin 
in this manuscript) were obtained from ThermoFisher Scien-
tific (Bleiswijk, the Netherlands). Vancomycin hydrochloride 
and all other chemicals used in this study were obtained from 
Sigma-Aldrich. The zebrafish medium (E3 medium) was 
prepared according to a standard protocol.42 
experimental setup
The experimental setup in the present study is schematically 
depicted in Figure S1.
Preparation of gelatin nanospheres
Gelatin nanospheres were prepared via a two-step coacerva-
tion method, as previously described in detail.27,43 In brief, 
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gelatin (1.25 g) was dissolved in Milli-Q water (25 mL) at 
50°C under magnetic stirring to form a 5 % (w/v) solution. 
High molecular weight chains of gelatin were precipitated 
by adding acetone (25 mL). After discarding the supernatant, 
Milli-Q water (25 mL) was added to redissolve the gelatin 
at 50°C under magnetic stirring, followed by adjusting the 
pH of the gelatin solution to 2.5 with 1 M HCl. Acetone 
(80 mL) was subsequently added (4 mL/min) under high-
speed (1,200 rpm) stirring to allow formation of gelatin 
nanospheres. Subsequently, the gelatin nanospheres were 
cross-linked using glutaraldehyde (25 wt%, 740 μL). After 
this overnight cross-linking reaction, glycine solution 
(100 mM, 105 mL) was added to terminate the cross-linking 
process. The gelatin nanospheres were washed in Milli-Q 
and collected via 3 cycles of washing and centrifuging 
(5,000 rpm, 60 minutes). The suspension of gelatin nano-
spheres in Milli-Q (18 mg/mL) was kept at 4°C for further 
use. The gelatin nanopsheres are stable in Milli-Q at least for 
3 months due to the absence of proteolytic enzymes.
Fluorescent labeling of gelatin 
nanospheres
To track gelatin nanospheres in the zebrafish larvae, gelatin 
nanospheres were fluorescent-labeled with a far red dye 
(DyLight™ 650 NHS esters) (designated as fluorescently 
labeled gelatin nanospheres) following the manufacturer’s 
protocol. In brief, gelatin nanospheres (200 mg) were dis-
persed in phosphate buffered saline (PBS, 20 mL). Sodium 
hydroxide solution (1 M) was then added to adjust the pH 
of the gelatin nanosphere suspension to 7.2. Subsequently, 
NHS ester solution (50 μg in 200 μL of N,N-dimethylfor-
mamide) was added to the gelatin nanosphere suspension 
to react for 1 hour under magnetic stirring (400 rpm). 
The fluorescently labeled gelatin nanospheres were sub-
sequently centrifuged and washed using Milli-Q water 
(5,000 rpm, 60 minutes). The suspension of fluorescently 
labeled gelatin nanospheres (18 mg/mL) was stored at 4°C 
for further use. 
characterization of gelatin nanospheres
The unlabeled and labeled gelatin nanospheres were sputter-
coated with gold, and the morphology of these gelatin nano-
spheres was examined using scanning electron microscopy 
(SEM; LEO 435 VP; Zeiss, Jena, Germany; Sigma-300, 
Zeiss). The zeta potential of the gelatin nanospheres was 
characterized by laser Doppler electrophoresis using a 
Zetasizer Nano-Z instrument (Malvern Instruments Ltd., 
Worcestershire, UK) in PBS buffer and Milli-Q water. The 
size of the gelatin nanospheres in swollen state was examined 
in 154 mM PBS at pH 7.4 and Milli-Q water at pH 7.0 by 
dynamic light scattering (DLS; Zetasizer Nano-S, Malvern 
Instruments Ltd., Worcestershire, UK). 
Zebrafish husbandry and maintenance 
of larvae
The zebrafish larvae used for studies using fluorescent 
microcopy were from the transgenic lines (mpeg1:Gal4/
UAS:Kaede) and (fms:Gal4/UAS:mCherry), which express 
green and red fluorescent proteins, respectively, in their 
macrophages.44,45 The larvae used for assessing treatment 
efficacy of S. aureus infection (see paragraph below) were 
from the wild-type Tupfel long fin (TL). The husbandry and 
maintenance of adult zebrafish followed the welfare regula-
tions of animals approved by the local animal welfare commit-
tee (Dierexperimentencommissie, DEC) and were described 
in detail before.40,43 After harvesting, zebrafish larvae were 
maintained in E3 medium as described.40,43
Microinjection of gelatin nanospheres 
into zebrafish larvae
At 3 days post-fertilization, zebrafish larvae were anesthe-
tized by using 0.03% tricaine (buffered 3 aminobenzoic 
acid ethyl ester; Sigma-Aldrich), placed in agarose plates 
(with U-shaped grooves, home-made) containing E3 
medium. Gelatin nanosphere suspension was vortexed for 
1 minute and subsequently loaded into a glass capillary 
(Harvard Apparatus, Holliston, MA, USA) which was con-
nected to an Eppendorf FemtoJet microinjector (Nijmegen, 
the Netherlands). The size of the capillary tip was adjusted 
to around 15 μm in diameter by breaking manually under a 
Leica M20 light microscope (Eindhoven, the Netherlands). 
This allowed injection of a volume of ~3 nL. To study 
the distribution of gelatin nanospheres and macrophage-
gelatin nanospheres interactions, the suspension of gelatin 
nanospheres was injected either into the blood circulation 
of zebrafish larvae via the Duct of Cuvier46 or into the tail 
muscle tissue,40,46 under a light microscope. 
Visualization of biodistribution of 
and macrophage response to gelatin 
nanospheres injected into zebrafish larvae 
We visualized the distribution of and the response of 
macrophages to the injected gelatin nanospheres in zebrafish 
larvae of the transgenic line (mpeg1:Gal4/UAS:Kaede) at 
3 and 24 hours post-injection by using confocal laser scan-
ning microscopy (Leica TCS SP8 SMD). The zebrafish 
larvae were anesthetized as described earlier and placed in 
a 35 mm glass-bottom culture dish (MatTek Corporation, 
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Ashland, MA, USA). The larvae were subsequently covered 
with 1.5 wt % low melting point agarose. The entire sample 
was then covered by E3 medium after solidification of the 
agarose. A series of Z-stack images were recorded and 
subsequently converted to three-dimensional (3D) videos 
using the Leica LAS X software. Figures explained in the 
results section and their corresponding 3D videos were in 
all cases recorded from one representative larva in each 
experimental group. Macrophages of zebrafish larvae of the 
transgenic line (mpeg1:Gal4/UAS:Kaede) express Kaede 
fluorescent protein. This fluorescent protein may undergo an 
irreversible color change from green to red upon UV illumi-
nation (350–400 nm), depending on the exposure time and 
energy level.47,48 However, in control experiments, this color 
conversion was not observed under the current experimental 
conditions (Figure S2).
Visualization of internalization of 
gelatin nanospheres by ThP-1-derived 
macrophages
THP-1-derived macrophages were cultured in medium 
containing gelatin nanospheres. Internalization of gelatin 
nanospheres by these macrophages in vitro was studied, 
as previously described in detail.43 In brief, THP-1 human 
monocytic cells were seeded onto Thermanox cover-
slips (ThermoFisher Scientific) at a density of 2.5 × 105 
cells/cm2 in a 24-well plate containing 500 μL of RPMI 
1640 medium (Gibco™, ThermoFisher Scientific, Paisley, 
Scotland). The medium was supplemented with fetal bovine 
serum (10%), streptomycin (100 μg/mL), and penicillin 
(100 U/mL). The cells were cultured at 37°C and under 
5% CO
2
. Phorbol-12-myristate-13-acetate (50 ng/mL, 
PMA; Sigma-Aldrich) was added to the culture medium to 
induce differentiation into macrophages. After culturing for 
48 hours, fluorescently labeled gelatin nanospheres in Milli-Q 
water (5 μL, 18 mg/mL) were added to the plate and the THP-
1-derived macrophages were incubated with these gelatin 
nanospheres for 24 hours. After incubation, Cell-Tracker™ 
CMFDA green (10 μM; ThermoFisher Scientific) was added 
to stain the cell cytoplasm. After an additional incubation for 
30 minutes, the cells were washed with PBS for 3 times and 
fixed with 4% paraformaldehyde. The nucleic acid of THP-1-
derived macrophages was stained with DAPI (Roche Applied 
Science, Mannheim, Germany), and subsequently mounted 
with ProLong® Diamond Antifade Mountant (ThermoFisher 
Scientific) for imaging using confocal microscopy. A series 
of Z-stack images were recorded and subsequently converted 
to 3D videos using the Leica LAS X software.
Visualization of internalization of 
vancomycin-loaded gelatin nanospheres 
by ThP-1-derived macrophages
To test if gelatin nanospheres can act as carriers for local 
delivery of antibiotics, THP-1-derived macrophages were 
cultured in medium containing vancomycin-loaded gelatin 
nanospheres. The cellular uptake of vancomycin-loaded 
gelatin nanospheres was studied using fluorescence micros-
copy. In brief, 100 μg of fluorescently labeled vancomycin 
was dissolved in 1 mL of a freshly prepared suspension of 
fluorescently labeled gelatin nanospheres in Milli-Q water 
(18 mg/mL) to form a suspension of vancomycin-loaded 
gelatin nanospheres. This suspension was equilibrated at 
4°C for 12 hours to allow for adsorption of vancomycin 
to the gelatin nanospheres by polyion formation between 
vancomycin and gelatin macromers. Previously we showed 
that the affinity between vancomycin and gelatin nanospheres 
was high, resulting in the absence of any burst-type release 
of vancomycin.27,28 Therefore, we assume that the loading 
efficiency of the gelatin nanospheres was high and the amount 
of unbound vancomycin low. Vancomycin was added to the 
suspension of gelatin nanospheres in order to ensure that all 
vancomycin was confined within the colloidal suspension. 
THP-1 human monocytic cells were cultured in 500 μL of 
culture medium, and differentiation into macrophages was 
induced with PMA. Subsequently, 5 μL of the suspension 
of vancomycin-loaded gelatin nanospheres were added to 
the culture medium and the macrophages were cultured 
for 24 hours. THP-1-derived macrophages were also incu-
bated with 5 μL of vancomycin solution in Milli-Q water 
(100 μg/mL) for 24 hours as control experiment. After 
incubation for 24 hours, the cells were washed with PBS for 
3 times and fixed with 4% paraformaldehyde. The nucleic 
acid and actin skeleton of the cells was stained with DAPI 
and Alexa Fluor® 568 Phalloidin (ThermoFisher Scientific), 
respectively. ProLong® Diamond Antifade Mountant was 
used to mount the cells for imaging. A series of Z-stack 
images were recorded and subsequently converted to 
3D videos using the Leica LAS X software.
Visualization of internalization of 
vancomycin-loaded gelatin nanospheres 
by macrophages in zebrafish larvae
To study internalization of vancomycin-loaded gelatin nano-
spheres in vivo, we injected the suspension of vancomycin-
loaded gelatin nanospheres intramuscularly into the tail 
muscle tissue of zebrafish larvae of the transgenic line 
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(fms:Gal4/UAS:mCherry) which express mCherry fluores-
cent protein in their macrophages, following the procedure 
described earlier. A solution of free vancomycin without 
gelatin nanospheres in Milli-Q water was also injected 
intramuscularly into a control group of larvae. The interac-
tion between zebrafish macrophages and vancomycin-loaded 
gelatin nanospheres or free vancomycin was monitored 
using confocal microscopy at 24 hours post-injection as 
described above. A series of Z-stack images were recorded 
and subsequently converted to 3D videos using the Leica 
LAS X software.
Visualization of co-localization of 
macrophages and bacteria in zebrafish 
larvae
We used fluorescence microscopy (Leica LM80) to record 
the co-localization of macrophages and bacteria in 1-day-
old zebrafish larvae. The zebrafish transgenic line (mpeg 1: 
Gal4/UAS: Kaede) and S. aureus RN4220 expressing 
mCherry fluorescent protein were used. The bacteria were 
cultured in tryptic soy broth for ~3–4 hours to reach the 
logarithmic growth phase at 37°C. Subsequently, bacteria 
were collected by centrifugation, washed repeatedly with 
PBS, and resuspended in Milli-Q water to a concentration 
adjusted to ~1,000 colony-forming unit (CFU)/nL. Zebrafish 
larvae were dechorionized, anaesthetized with tricaine, and 
aligned in an agar plate containing E3 medium for injec-
tions. At 30 hours post-fertilization, 3 nL of the suspension 
of S. aureus bacteria was injected into the blood circulation 
of zebrafish larvae via the blood island46 to reach a chal-
lenge dose of ~3,000 CFU per larva, which was verified 
by quantitative culture of 6 randomly selected infected 
larvae crushed using a MagNA lyser (Roche, Almere, the 
Netherlands). At 32 hours post-fertilization, S. aureus-
infected zebrafish larvae were imaged using fluorescence 
microscopy (Leica LM80, Eindhoven, the Netherlands) 
under bright field, and with the mCherry and the GFP filters 
under optimized setting.
Treatment of S. aureus-infected zebrafish 
larvae with vancomycin using gelatin 
nanospheres as carriers
To investigate if the antibacterial efficacy of vancomycin 
can be enhanced upon local delivery from vancomycin-
loaded gelatin nanospheres, we injected ~3,000 CFU 
of S. aureus ATCC 49230 expressing green fluorescent 
protein49 intravenously into wild-type TL zebrafish larvae 
as described earlier, at 30 hours post-fertilization. After 
injection of the bacteria, the larvae were randomly divided 
into experimental groups for subsequent treatment of the 
infection. At 32 hours post-fertilization, so at 2 hours after 
infection, 3 nL of a freshly prepared suspension of fluores-
cently labeled gelatin nanospheres (18 mg/mL, in Milli-Q 
water) containing 0.13 mg/mL vancomycin, or 3 nL of 
0.13 mg/mL vancomycin dissolved in Milli-Q water, or 3 nL 
of a freshly prepared suspension of gelatin nanospheres in 
Milli-Q, or 3 nL of Milli-Q water as mock treatment control, 
was injected into the blood circulation of infected larvae 
via the blood island. To prepare vancomycin-loaded gelatin 
nanospheres, vancomycin was dissolved in the liquid phase 
of the suspension of gelatin nanospheres. This vancomycin-
loaded gelatin nanosphere suspension was equilibrated at 
4°C for 12 hours to allow for adsorption of vancomycin to 
the gelatin nanospheres through polyion formation between 
vancomycin and gelatin macromers. This vancomycin dose 
of ~0.4 μg per larva was selected since this dose failed to 
protect larvae against the aforementioned dose of S. aureus, 
based on our pilot experiments. An infection-free control 
group received an injection of Milli-Q water instead of 
S. aureus, and another injection of Milli-Q water instead 
of antibiotic treatment, at the respective time points. This 
control group was included to assess the possible harmful 
effect caused by the double injection procedure. Survival 
of the larvae in each group was monitored daily (heartbeat 
and movement) from the day of injection until 4 days 
post-injection. 
statistics
All statistics were carried out using Graphpad Prism version 
7.0. Percent survival of zebrafish larvae was analyzed using 
the Kaplan–Meier method. Differences in survival between 
pairs of groups over the entire time period of the experiment 
were statistically analyzed using the Log-rank test method.
Results
Characterization of fluorescently labeled 
gelatin nanospheres
Fluorescent labeling of gelatin nanospheres with the far-red 
dye (DyLight™ 650) did not influence the morphology of the 
dehydrated nanospheres. The non-labeled and labeled nano-
spheres in dry state had a comparable size range (Figure 1). 
For gelatin nanospheres in swollen state (PBS buffer), the 
fluorescent labeling caused a slight increase in the average 
size of gelatin nanospheres from 329 to 387 nm (Table 1). The 
average size of the fluorescently labeled gelatin nanospheres 
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in swollen state in Milli-Q water was 676 nm. Both the size 
and charge of the gelatin nanospheres were smaller in PBS 
buffer with high ionic strength as compared to Milli-Q water, 
which has lower ionic strength. These effects were caused 
by screening of the negative charges along the gelatin mac-
romers, thereby reducing the repulsive interactions between 
gelatin macromers.
Distribution of gelatin nanospheres and 
their interactions with macrophages after 
intravenous injection into zebrafish larvae
To investigate the distribution of gelatin nanospheres in the 
blood circulation of live animals and the elicited response of 
macrophages in vivo using confocal fluorescence micros-
copy, fluorescently labeled gelatin nanospheres were injected 
intravenously into the Duct of Cuvier of  3-day-old zebrafish 
larvae expressing Kaede fluorescent proteins (green) in their 
macrophages (Figure 2A and B; Figure 3A and B). At 3 hours 
post-injection, the injected gelatin nanospheres had already 
spread throughout the blood vessels of the larvae (Figure 2C). 
The majority of the observed macrophages was patrolling 
the blood vessels, while few macrophages co-localized with 
gelatin nanospheres in the caudal blood vessel (Figure 2D, 
blue dashed box; Figure 2E; Video S1). However, the gela-
tin nanospheres that were not associated with macrophages 
seemed to be clustered, suggesting internalization by other 
non-labeled cell types such as neutrophils, as for instance also 
observed by other in vivo studies on the cellular uptake of 
silica or PLGA nanoparticles using zebrafish larvae.34,35 The 
agglomeration of the non-internalized gelatin nanospheres 
in the blood circulation may be caused by the high ionic 
strength of the blood. The high ionic strength of blood likely 
screened the repulsive interactions between the negatively 
charged gelatin nanospheres,22 as the zeta-potential of gelatin 
nanospheres in PBS buffer (with a similar ionic strength level 
compared to that of blood) was lower than that of gelatin 
nanospheres in Milli-Q water (Table 1). At 24 hours post-
injection, the co-localization of the gelatin nanospheres and 
the macrophages was mainly observed in the area surround-
ing the yolk sac of the larvae (Figure 3C and D, blue dashed 
box; Figure 3E; Video S2). 
Distribution of gelatin nanospheres and 
their interactions with macrophages 
after intramuscular injection into 
zebrafish larvae
In order to investigate the distribution of gelatin nanospheres 
in muscle tissue of the zebrafish larvae and the provoked 
response of macrophages in vivo using confocal fluorescence 
microscopy, fluorescently labeled gelatin nanospheres were 
injected intramuscularly into 3-day-old zebrafish larvae 
with macrophages expressing the Kaede green fluorescent 
protein (Figure 4B and C; Figure 5A and B). In contrast to 
intravenous injection of gelatin nanospheres which resulted 
in spreading of the gelatin nanospheres throughout the cir-
culation (Figure 2C), the intramuscularly injected gelatin 
nanospheres only spread throughout the muscle tissue close to 
the injection site at 3 hours post-injection (Figure 4A and D). 
Although some macrophages had already been attracted to 
this tissue area at this early time point, only few macrophages 
Figure 1 scanning electronic micrograph of dehydrated gelatin nanospheres without (A) and with (B) fluorescent labeling. Scale bars represent 500 nm.
? ?
Table 1 Parameters of non-labeled and fluorescently labeled 
gelatin nanospheres in swollen state in different solutions
Parameters Non-labeled Fluorescent-
labeled
Fluorescent-
labeled
PBS (154 mM, 
pH 7.4)
PBS Milli-Q water 
(pH 7)
Particle size (nm) 329 ± 5 387 ± 7 676 ± 13
ζ-potential (mV) −6.63 ± 0.86 −6.55 ± 0.20 −25.60 ± 0.45
Abbreviation: PBs, phosphate buffered saline.
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Figure 2 Distribution of zebrafish macrophages and gelatin nanospheres at 3 hours after intravenous injection of gelatin nanospheres into a 3-day-old zebrafish larva. 
(A) Bright field image; (B) green fluorescent macrophages; (C) red fluorescent gelatin nanospheres; (D) merged image of (B) and (C) with co-localization of gelatin 
nanospheres and macrophages depicted in yellow. several macrophages co-localized with gelatin nanospheres in the caudal blood vessel of the larva (blue dashed box in D). 
scale bars represent 500 μm. (E) Magnification of the boxed area in (D). scale bar represents 200 μm.
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seemed to co-localize with gelatin nanospheres (Figure 4E, 
white dashed box; Video S3). 
At 24 hours post-injection, the original mass of gelatin 
nanospheres had been dispersed into separate clusters, but 
the majority of the gelatin nanospheres was still confined 
to the muscle tissue near the injection site and engulfed 
by macrophages (Figure 5C and D). The corresponding 
video (Video S4) confirmed that the gelatin nanospheres 
that co-localized with the zebrafish macrophages were 
internalized. 
Figure 3 Distribution of zebrafish macrophages and gelatin nanospheres at 24 hours after intravenous injection of gelatin nanospheres into a 3-day-old zebrafish larva. 
(A) Bright field image; (B) green fluorescent macrophages; (C) red fluorescent gelatin nanospheres; (D) merged image of (B) and (C) with co-localization of gelatin 
nanospheres and macrophages depicted in yellow. The majority of the observed macrophages co-localized with gelatin nanospheres in the area surrounding the yolk sac of 
the larva (blue dashed box in D). scale bars represent 500 μm. (E) Magnification of the boxed area in (D). scale bar represents 200 μm.
?
?
?
?
?
 
In
te
rn
at
io
na
l J
ou
rn
al
 o
f N
an
om
ed
ici
ne
 d
ow
nl
oa
de
d 
fro
m
 h
ttp
s:
//w
ww
.d
ov
ep
re
ss
.c
om
/ b
y 
13
1.
17
4.
24
8.
14
9 
on
 1
5-
O
ct
-2
01
8
Fo
r p
er
so
na
l u
se
 o
nl
y.
Powered by TCPDF (www.tcpdf.org)
                               1 / 1
International Journal of Nanomedicine 2018:13 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
5385
Local delivery of vancomycin from gelatin nanospheres in zebrafish larvae
Internalization of gelatin nanospheres and 
vancomycin-loaded gelatin nanospheres 
by ThP-1-derived macrophages in vitro
To assess whether internalization of gelatin nanospheres by 
macrophages as observed in the zebrafish larvae also would 
occur in human macrophages in vitro, we cultured THP-
1-derived macrophages in cell culture medium containing 
gelatin nanospheres. Internalization of gelatin nanospheres 
by these macrophages was indeed observed after 24 hours of 
culture (Figure 6A), which was confirmed by the correspond-
ing video (Video S5).
To study the potential internalization of gelatin nano-
spheres by macrophages in vitro, THP-1-derived macrophages 
were cultured in medium containing vancomycin-loaded 
gelatin nanospheres. The vancomycin-loaded gelatin nano-
spheres were internalized by the macrophages after 24 hours 
of culture (Figure 6B; Video S6). The majority of the internal-
ized vancomycin co-localized with the gelatin nanospheres 
intracellularly within the THP-1-derived macrophages, 
although fluorescent signal of vancomycin not associated 
with gelatin nanospheres was also detected in the cytosol of 
the macrophages. This suggests that this vancomycin was 
partially released intracellularly from gelatin nanospheres in 
the cytosol of the macrophages (Figure 6B). In the control 
group of macrophages cultured with free vancomycin 
without gelatin nanospheres as carriers, no internalized 
Figure 4 Distribution of zebrafish macrophages and gelatin nanospheres in the muscle tissue surrounding the injection site at 3 hours after intramuscular injection of gelatin 
nanospheres into a 3-day-old zebrafish larva. (A) Merged overview image with white dashed box indicating the tissue area of injection (injection site indicated by arrow). 
(B–E) Magnification of the boxed area of (A); (B) depicting the bright field image; (C) green fluorescent macrophages; (D) red fluorescent gelatin nanospheres; (E) merged 
image of (C) and (D) with co-localization of gelatin nanospheres and macrophages depicted in yellow. several macrophages co-localized with gelatin nanospheres (E, white 
dashed box). scale bar in (A) represents 500 μm and in (B–E) 200 μm.
A
B C
D E
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vancomycin was detected inside the cells after 24 hours of 
culture (Figure 6C). 
Internalization of vancomycin-loaded 
gelatin nanospheres by macrophages of 
zebrafish larvae
To study the potential delivery of vancomycin by using 
gelatin nanospheres into macrophages in vivo, we injected 
vancomycin-loaded gelatin nanospheres into the muscle tissue 
of 3-day-old zebrafish larvae with macrophages expressing 
mCherry fluorescent protein (red) and studied the provoked 
response of macrophages. At 24 hours post-injection, 
co-localization of vancomycin-loaded gelatin nanospheres 
and macrophages of the zebrafish larvae was observed, 
suggesting cellular internalization of the vancomycin-
loaded gelatin nanospheres (Figure 7A, co-localization 
indicated by white arrows; Figure 7B; Figure S3). Inter-
nalization of vancomycin-loaded gelatin nanospheres was 
also shown in the corresponding videos, since internalized 
vancomycin and gelatin nanospheres were observed within 
vacuole-like structures inside the zebrafish macrophages 
(Videos S7 and S8). Upon injection of free vancomycin 
without gelatin nanospheres as carriers, co-localization of 
vancomycin and zebrafish macrophages was hardly observed 
(data not shown).
Phagocytosis of bacteria by macrophages 
of zebrafish larvae
To investigate the effect of treatment with vancomycin-
loaded gelatin nanospheres on intracellular S. aureus, we 
first assessed if macrophages in 1-day-old zebrafish larvae 
were able to phagocytose S. aureus. To this end, we injected 
S. aureus expressing mCherry fluorescent protein (red) intra-
venously into 1-day-old zebrafish larvae with macrophages 
expressing Kaede fluorescent protein (green) (Figure 8A). 
At 2 hours post-injection of bacteria, the majority of the 
bacteria co-localized with zebrafish macrophages as observed 
using fluorescence microscopy, suggesting that the bacteria 
were phagocytosed by the macrophages (Figure 8B–D). The 
bacteria that did not associate with macrophages also seemed 
to be clustered (Figure 8C), suggesting that they may have 
been phagocytosed by other phagocytes such as neutrophils, 
Figure 5 Co-localization of zebrafish macrophages and gelatin nanospheres in the muscle tissue surrounding the injection site at 24 hours after intramuscular injection of 
gelatin nanospheres into a 3-day-old zebrafish larva. (A) Bright field image; (B) green fluorescent macrophages; (C) red fluorescent gelatin nanospheres; (D) merged image 
of (B) and (C), with co-localization of macrophages and gelatin nanospheres depicted in yellow. The majority of the injected gelatin nanospheres was confined to the tissue 
area of injection and engulfed by macrophages, as shown in the merged image (D). scale bars represent 100 μm.
A B
C D
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which were non-labeled in the fish line used in this experi-
ment). This early phagocytosis is in accordance with results 
reported in a study that used a similar zebrafish larvae 
S. aureus infection model.33 Thus, our model allowed studies 
on the therapeutic efficacy of vancomycin-loaded gelatin 
nanospheres against intracellular bacterial infection.
Enhanced protection of zebrafish 
larvae against S. aureus infection using 
vancomycin-loaded gelatin nanospheres
To assess the potential of gelatin nanospheres as carriers to 
enhance the antibacterial activity of vancomycin in vivo, 
we injected S. aureus intravenously into zebrafish larvae at 
1 day post-fertilization and subsequently treated the infected 
larvae with a single intravenous injection of vancomycin-
loaded gelatin nanospheres, free vancomycin, or only gelatin 
nanospheres at 2 hours after the S. aureus injection. A dose 
of vancomycin of 0.4 ng per larva was selected since this 
dose failed to protect the S. aureus-infected larvae when 
injected without any carrier and could thus be used to study 
the potential of gelatin nanospheres as carriers to improve 
the efficacy of vancomycin.
The dual injection procedure itself caused 20% of 
larvae in the infection-free control group to die at 1 day 
Figure 6 In vitro internalization of fluorescently labeled gelatin nanospheres (GNs, A) and GNs loaded with fluorescent-labeled vancomycin (V-GNs, B) by ThP-1-derived 
macrophages after 24 hours of culture. cells incubated with free vancomycin without gNs as carriers were used as controls (C). Nucleic acid of the cells was stained with 
DaPI/blue, and cytoplasm and actin skeleton with cell-Tracker™ cMFDa/green (in A) and alexa Fluor® 568 Phalloidin/red (in B and C), respectively. cell-Tracker™ 
CMFDA/green also stained nucleic acid of the cells. The fluorescent-labeled GNs were displayed in red (in A) and in cyan (in B). scale bars represent 20 μm (in A and B) 
and 10 μm (in C).
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Figure 7 In vivo cellular internalization of fluorescently labeled gelatin nanospheres (GNs, blue) and fluorescent-labeled vancomycin (green) by fluorescent zebrafish 
macrophages (red) at 24 hours after intramuscular injection of vancomycin-loaded GNs into a 1-day-old zebrafish larva. (A) Interactions between zebrafish macrophages 
and vancomycin-loaded gNs observed in the muscle tissue surrounding the injection site. The white arrows point at vacuole-like structures of macrophages containing 
internalized gelatin nanospheres and vancomycin. (B) High magnification of a zebrafish macrophage containing the internalized gelatin nanospheres and vancomycin. Scale 
bars in A and B represent 50 and 10 μm, respectively.
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Figure 8 Co-localization of green fluorescent zebrafish macrophages (green) and red fluorescent S. aureus at 2 hours after intravenous injection of bacteria into a 1-day-old 
zebrafish larva. The median dose of S. aureus assessed directly after injection in 6 control larvae was 3,000 cFU/larva. (A) Merged overview image; (B) distribution of the 
fluorescent macrophages and injected S. aureus; white dashed boxes indicate the areas of the recorded co-localization enlarged in C and D; (C and D) high magnification of 
the recorded co-localization, indicated by arrows. scale bars in A–B and C–D represent 500 and 100 μm, respectively. 
Abbreviation: cFU, colony-forming unit.
A
B
C D
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post-injection. Subsequently, survival in this infection-free 
group remained 80% until 4 days post-injection (Figure 9). 
Survival of the infected larvae receiving free vancomycin or 
only gelatin nanospheres dramatically decreased to ~20% 
already at 1 day post-injection and decreased further during 
the following 3 days (Figure 9). Survival in these groups was 
not statistically different from that in the control group treated 
with Milli-Q water only (P=0.43 and 0.64). In contrast, over-
time survival of larvae receiving vancomycin-loaded gelatin 
nanospheres was statistically significantly higher than that 
of larvae receiving free vancomycin (P=0.01) (Figure 9). 
During the first 3 days post-injection, survival rate of larvae 
receiving vancomycin-loaded gelatin nanospheres was higher 
than that of the other groups, which, however, gradually 
decreased to a level similar to that of the other groups at 
4 days post-injection. These results showed that treatment 
with vancomycin-loaded gelatin nanospheres delayed the 
mortality of S. aureus-infected zebrafish larvae compared 
to systemic administration of free vancomycin, although 
this single dose of vancomycin-loaded gelatin nanospheres 
was not sufficient to protect the larvae until the end of the 
experiment. 
Discussion
The aim of the present study was to investigate the feasibility 
of gelatin nanospheres for local delivery of vancomycin 
in vivo. Using transgenic zebrafish larvae with macrophages 
expressing fluorescent proteins, we visualized in real time – 
for the first time – the biodistribution of gelatin nanospheres 
in a live animal, which was dependent on the administration 
route (ie, intravenous or intramuscular injection). Moreover, 
our results showed that vancomycin-loaded gelatin nano-
spheres facilitated internalization of vancomycin by mac-
rophages in zebrafish larvae in vivo and by THP-1-derived 
macrophages in vitro. Systemically delivered vancomycin, 
on the other hand, was hardly internalized by macrophages 
without the use of gelatin nanospheres. Treatment with 
a single dose of vancomycin-loaded gelatin nanospheres 
delayed the mortality of S. aureus-infected zebrafish larvae, 
indicating the improved therapeutic efficacy of vancomycin 
against (intracellular) S. aureus infection in vivo.
A major problem with respect to treatment of infection 
using antibiotics is the limited therapeutic efficacy of many 
antibiotics against pathogens inside cells. In the present 
study, we investigated if gelatin nanospheres can improve 
internalization of vancomycin by macrophages, since this 
cell type is known to host intracellularly surviving bacterial 
pathogens50 and plays an important role in the phagocytosis 
of nanocarriers used for local delivery.51,52 Our results showed 
in a qualitative manner that the use of gelatin nanospheres 
as carriers allowed for internalization of vancomycin by 
macrophages within zebrafish larvae in vivo and THP-1-
derived macrophages in vitro. These observations are in 
line with previously obtained data on the release kinetics of 
vancomycin from gelatin nanospheres,27,28 which indicated 
that vancomycin was adsorbed tightly to gelatin macromers 
in gelatin nanospheres. This strong affinity between gelatin 
nanospheres and vancomycin facilitated intracellular delivery 
of vancomycin following internalization of vancomycin-
loaded gelatin nanospheres by macrophages. Next, we 
studied whether the antibacterial efficacy of vancomycin 
was improved by the use of gelatin nanospheres as carriers 
using a zebrafish larvae S. aureus infection model. In this 
model, the majority of the infecting S. aureus had been 
phagocytosed prior to injection of antibiotics and nano-
spheres. Vancomycin was selected since this antibiotic is 
not effective in treating intracellular bacteria,7,9,41 which was 
confirmed by our study since a single dose of free vancomy-
cin did not protect zebrafish larvae from S. aureus infection. 
Treatment with vancomycin-loaded gelatin nanospheres 
statistically significantly increased the survival over time 
Figure 9 Percent survival (%) of S. aureus-infected zebrafish larvae receiving different 
treatments, monitored from the day of injection until 4 days post-injection. The 
median dose of S. aureus assessed directly after injection in control larvae was 
3,200 cFU per larva. The infected larvae were treated with vancomycin-loaded 
gelatin nanospheres (V-gNs), free vancomycin, or only gelatin nanospheres (gNs). 
Injection of Milli-Q water was used as mock treatment. larvae receiving two 
injections of Milli-Q water (infection-free) were used as controls for the injection 
procedure. The group size of infected larvae was between 32 and 35 larvae per group 
at the start of the experiment. The group size of infection-free larvae was 10 larvae. 
Survival of zebrafish larvae receiving locally delivered vancomycin (V-GNs) was 
statistically significantly higher than survival of zebrafish larvae receiving systemically 
delivered vancomycin (P=0.01).
Abbreviation: cFU, colony-forming unit.
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of the S. aureus-infected larvae. In the first 3 days after 
treatment, higher survival levels were noted. The positive 
effect of vancomycin-loaded gelatin nanospheres on survival 
of zebrafish larvae can be attributed to either intracellular 
delivery and/or extracellular release of vancomycin from 
gelatin nanospheres contributing to the clearance of free 
bacteria in the blood circulation of larvae. Future studies 
should be executed in animal models, which allow quan-
tification of intracellular versus extracellular delivery of 
vancomycin from gelatin nanospheres in order to elucidate 
the mechanism of action of vancomycin-loaded gelatin 
nanospheres for treatment of S. aureus infections.
The higher over-time survival of S. aureus-infected larvae 
treated with vancomycin-loaded gelatin nanospheres was 
characterized by high survival rates during the first 3 days 
after treatment. This seems to correlate with the relatively 
rapid release of vancomycin from gelatin nanospheres, as 
reported in our previous in vitro studies.27–29 The release 
kinetics of antibiotics from gelatin nanospheres depends 
strongly on the binding affinity of antibiotics to gelatin 
nanospheres.27 This affinity is controlled by several factors 
including the local pH and ionic strength as well as the 
enzymatic degradation of gelatin nanospheres.27 Monitor-
ing the release kinetics of vancomycin from gelatin nano-
spheres in vivo was not possible for the current zebrafish 
larva model for various reasons. First, only small volumes 
of vancomycin (3 nL) can be administrated to the small 
larvae, which would result in final concentrations below 
the detection limit of common analytical techniques such 
as high-performance liquid chromatography. Moreover, 
quantification of internalized vancomycin using imag-
ing analysis is not possible due to technical limitations. 
Hence, in vivo release kinetics should be studied using 
other animal models (eg, mouse) in order to optimize the 
formulation of vancomycin-loaded gelatin nanospheres. 
Neutrophils and macrophages are suggested to be impor-
tant niches of intracellular S. aureus in zebrafish larvae.53 Thus, 
we speculate that low numbers of S. aureus may survive in 
neutrophils and macrophages of the larvae, forming reser-
voirs of infection at later time points. This is in accordance 
with the pathogenesis of S. aureus infection a similar larva 
model described previously.33 Therefore, repeated delivery 
of multiple doses of vancomycin-loaded gelatin nanospheres 
may improve the efficacy of vancomycin-loaded gelatin 
nanospheres on S. aureus infection in the zebrafish larva 
model. Phagolysosomal escape of bacteria into the cytosol 
of the niche cells is a crucial element in the pathogenesis of 
intracellular infection. This mechanism has been reported for 
S. aureus as well.54 Therefore, cytosolic release of antibiotics 
is desired to combat the bacteria residing in the cytosol of the 
cells. Interestingly, in the present study, a minor portion of the 
internalized vancomycin was observed separate from gelatin 
nanospheres within the cytosol of THP-1-derived macrophages 
in vitro, suggesting that gelatin nanosphere-based systems 
are suitable for cytosolic release of antibiotics. These data 
are, however, based on qualitative observation only and need 
quantitative confirmation in suitable larger animal models.
Several other intracellular delivery systems for antibiotics 
have been reported recently. For instance, a liposome-based 
system for intracellular delivery of vancomycin against 
S. aureus infection has been developed and successfully tested 
in a mouse model.41 However, liposomes have poor stability 
in biological fluids and may not be protective for the loaded 
drugs.12 Meanwhile, the drug payload of liposome-based sys-
tems is relatively low.11 Synthetic polymer nanoparticles are 
more stable than liposomes, but several types of polymeric 
nanoparticles are potentially toxic.12 The suitability of gelatin 
nanospheres as carriers for growth factors facilitating bone 
regeneration has been shown in various animal models such as 
rats,23,24 illustrating the biocompatibility of gelatin nanospheres 
and effectiveness of release of their bioactive cargos. The pres-
ent study provides evidence that gelatin nanospheres can be 
used as nanocarriers to facilitate local delivery of antibacterial 
agents such as vancomycin. These nanospheres might also be 
used for local delivery of other types of antibiotics (eg, amino-
glycosides or macrolides) or antimicrobial peptides. In that way, 
our gelatin nanosphere-based antibiotic delivery system may 
improve the efficacy of antibiotic delivery to eradicate intracel-
lular staphylococci, possibly even antibiotic-tolerant bacterial 
phenotypes such as small colony variants of S. aureus55 or other 
intracellular pathogens such as Mycobacterium tuberculosis.56 
As a consequence, the treatment of infections associated with 
intracellular bacteria may be improved considerably. Alterna-
tively, gelatin nanospheres loaded with antibiotics can also be 
incorporated within coatings on medical implants and devices28 
to tailor the release of antibiotics from implant surfaces to treat 
osteomyelitis and biomaterial-associated infections. 
Conclusion
In the present study, we analyzed the biodistribution of 
gelatin nanospheres in zebrafish larvae in real time and 
showed that their distribution depended on the route of 
administration (ie, intravenous or intramuscular injection). 
The gelatin nanospheres were shown to be internalized by 
macrophages within zebrafish larvae and by THP-1-derived 
macrophages. Gelatin nanospheres facilitated internaliza-
tion of vancomycin by macrophages both in vitro and in 
vivo, as opposed to poor internalization of systemically 
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delivered vancomycin without gelatin nanospheres. More-
over, survival of zebrafish larvae infected with S. aureus 
was significantly higher following local delivery of vanco-
mycin-loaded gelatin nanospheres as compared to survival 
after systemic delivery of free vancomycin over time, in 
particularly during the first 3 days. The present study dem-
onstrates that gelatin nanospheres are promising nanocarriers 
to facilitate local delivery of vancomycin to treat infections. 
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Supplementary materials
Figure S1 The schematic experimental setup of the present study.
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Figure S2 Detection of the Kaede fluorescent protein expressed in zebrafish macrophages at 3 hours post-intramuscular injection of PBS into a 3-day-old transgenic 
zebrafish larva (mpeg 1: Kaede). The Kaede fluorescent protein may undergo an irreversible photoconversion from green to red fluorescence upon UV illumination 
(350–400 nm), depending on the exposure time and energy levels. (A) Merged image of the bright field and green channel image; (B) green channel image; (C) red channel 
image; (D) merged image of (B) and (C). The white dashed boxes indicate the location of the Kaede protein expressing macrophages in the muscle tissue area of injection. 
after illumination, no red signal was detected in these macrophages in the red channel (C), indicating that no color conversion of Kaede from green to red occurred under 
the setting used in the present study. Although the pigment cells of these zebrafish embryos show autofluorescence both in green and in red (fluorescence detected outside 
of the white dashed box in B–D), they mainly lined up at the border of the embryo trunk. They were not motile and not present in the area of injection. Therefore, the 
autofluorescence of pigment cells did not influence the recording of the macrophage responses in muscle tissue. Scale bars represent 100 μm.
Abbreviations: PBs, phosphate buffered saline; UV, ultra violet.
? ? ? ?
Figure S3 A zebrafish macrophage (red) containing internalized fluorescently labeled gelatin nanospheres (GNs, blue) and fluorescent-labeled vancomycin (green) at 24 
hours after intramuscular injection of vancomycin-loaded GNs into a 3-day-old zebrafish larva. Scale bars represent 10 μm.
?????????? ??? ?????????? ??????
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Video S1 Three-dimensional (3D) video showing the distribution of fluorescently 
labeled gelatin nanospheres (red) and Kaede fluorescent protein expressing 
macrophages (green) at 3 hours post-intravenous injection of gelatin nanospheres 
into a 3-day-old zebrafish larva. Parts of the embryo such as the yolk and head were 
not entirely shown in this video since the maximum depth of the employed Z-stack 
was limited. This 3D video was converted from a series of Z-stack images shown in 
Figure 2. scale bar represents 500 μm.
Video S2 Three-dimensional (3D) video showing the distribution of fluorescently 
labeled gelatin nanospheres (red) and Kaede fluorescent protein expressing 
macrophages (green) at 24 hours post-intravenous injection of gelatin nanospheres 
into a 3-day-old zebrafish larva. Co-localization of gelatin nanospheres and 
macrophages was clearly observed in the area surrounding the yolk of the embryo. 
Parts of the embryo such as the yolk and head were not entirely shown in this 
video since the maximum depth of the employed Z-stack was limited. This 3D video 
was converted from a series of the Z-stack images shown in Figure 3. scale bar 
represents 500 μm.
Video S3 Three-dimensional (3D) video showing the distribution of fluorescently 
labeled gelatin nanospheres (red) and Kaede fluorescent protein expressing 
zebrafish macrophages (green) in the muscle tissue of injection at 3 hours post-
intramuscular injection of gelatin nanospheres into a 3-day-old zebrafish larva. This 
video was converted from a series of the Z-stack images shown in Figure 4. scale 
bar represents 200 μm.
Video S4 Three-dimensional (3D) video showing the distribution of fluorescently 
labeled gelatin nanospheres (red) and Kaede fluorescent protein expressing 
zebrafish macrophages (green) in the muscle tissue of injection at 24 hours post-
intramuscular injection of gelatin nanospheres into a 3-day-old zebrafish larva. The 
majority of the injected gelatin nanospheres was engulfed by the macrophages. This 
video was converted from a series of the Z-stack images shown in Figure 5. scale 
bar represents 100 μm.
Video S5 Three-dimensional (3D) video showing the internalization of fluorescently 
labeled gelatin nanospheres (red) by ThP-1 macrophages after 24 hours of culture. 
The cells appeared turquoise due to the merge of the colors of their nucleic acid 
which was stained both by DaPI and cell-Tracker™ cMFDa/green. Their cytoplasm 
was stained by cell-Tracker™ cMFDa/green. scale bar represents 50 μm.
Video S6 Three-dimensional (3D) video showing the internalization of vancomycin-
loaded gelatin nanospheres by ThP-1 macrophages after 24 hours of culture. 
The nucleic acid and actin of the cells were stained by DaPI and alexa Fluor® 
594 Phalloidin, respectively. Fluorescent-labeled vancomycin and gelatin nanospheres 
were shown in green and cyan, respectively. This video was converted from a series 
of the Z-stack images shown in Figure 6. scale bar represents 10 μm.
Video S7 Three-dimensional (3D) video showing the internalization of fluorescent-
labeled vancomycin (green) in vacuole-like structures of zebrafish macrophage 
expressing mCherry fluorescent proteins (red) at 24 hours post-intramuscular 
injection of vancomycin-loaded gelatin nanospheres into a 3-day-old zebrafish 
larva. This video was converted from a series of the Z-stack images shown in 
(B) in Figure 7, excluding the blue channel images of fluorescently labeled gelatin 
nanospheres. scale bars represent 10 μm.
Video S8 Three-dimensional (3D) video showing the internalization of fluorescently 
labeled gelatin nanospheres (blue) in the vacuole-like structures of the mcherry 
fluorescent protein (red) expressing zebrafish macrophage as shown in Video S7 
at 24 hours post-intramuscular injection of vancomycin-loaded gelatin nanospheres 
into a 3-day-old zebrafish larva. This video was converted from a series of the 
Z-stack images shown in (B) in Figure 7, excluding the green channel images of 
fluorescent-labeled vancomycin. Scale bars represent 10 μm.
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